Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects. (Q50174020)
Jump to navigation
Jump to search
scientific article published on 2 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects. |
scientific article published on 2 March 2007 |
Statements
Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects (English)
Adam Lloyd
Nishma Patel
Claus Runge
Christa Claes